Company Information

  

Address: ONE MARINA PARK DR.  
City: BOSTON 
State: MA 
Zip Code: 02210 
Telephone: 617-466-3500 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a commercial stage biopharmaceutical company focused on bringing innovative medicines to people with renal disease. Our long-term vision is to build a leading renal company. Our marketed product, Auryxia (ferric citrate), which is an orally available, absorbable, iron-based medicine is approved in the United States for the control of serum phosphorus levels in patients with chronic kidney disease, or CKD, on dialysis. Ferric citrate is also approved in Japan under the trade name Riona and marketed by our Japanese partner, Japan Tobacco Inc., or JT, and its subsidiary, Torii Pharmaceutical Co. Ltd., or Torii, and approved in Europe as Fexeric. We are also investigating the use of ferric citrate for the treatment of iron deficiency anemia, or IDA, in adults with non-dialysis dependent, CKD, or NDD-CKD, and, pending potential approval for this indication, plan to leverage our U.S. clinical and commercial infrastructure and treat many more people with CKD.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-1.50NAN/E
06/2017-1.71NAN/E
03/2017-1.34NAN/E
12/2016-1.52NAN/E
09/2016-1.56NAN/E
06/2016-1.47NAN/E
03/2016-1.30NAN/E
12/2015-1.19NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.19Total Liab/Total Assets1.06
Net Inc/Total Assets-1.14Total Liab/Inv Cap1.25
Net Inc/Inv Cap-1.34Total Liab/Comm Equity0.18
Pretax Inc/Net Sales-5.03Interest Coverage RatioNA
Net Inc/Net Sales-5.04Curr Debt/EquityNA
Cash Flow/Net Sales-2.71LTD/Equity-15.07
SG&A/NetSales2.64Total Debt/Equity-15.07
Asset Utilization   Liquidity  
Net Receivables Turnover6.71Quick Ratio5.58
Inventory Turnover1.49Current Ratio6.17
Inventory Day Sales0.01Net Rec/Curr Assets0.04
Net Sales/Work Cap0.29Inv/Curr Assets0.10
Net Sales/PP&E7.60  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) 15.00 15.15 11.82 9.53
Cost of Goods Sold 6.69 5.00 5.06 14.22
Selling & Admin Exps 22.75 24.99 23.10 23.04
Operating Income -23.72 -23.85 -23.11 -33.91
Interest Exp NA NA NA NA
Pretax Income -23.48 -86.48 -23.00 -33.76
Other Income 0.24 -62.63 0.11 0.14
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -23.50 -86.50 -23.02 -33.78

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 114.00 140.53 90.91 111.81
Receivables - Total 9.20 8.46 6.15 5.24
Inventories - Total 26.01 18.09 12.59 12.68
Total Current Assets 164.78 175.71 119.31 132.90
Net Property, Plant & Equipment 4.70 4.17 3.98 4.21
Total Assets 173.82 184.19 127.70 141.43
Liabilities        
Accounts Payable 36.54 30.15 21.76 21.19
Debt in Current Liabilities NA NA NA 0.00
Total Current Liabilities 36.92 30.52 22.12 21.55
Long-Term Debt 125.00 125.00 125.00 125.00
Total Liabilities 164.86 158.54 150.22 149.72
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.12 0.12 0.11 0.11
Retained Earnings -968.11 -944.61 -858.11 -835.10
Treasury Stock -0.36 -0.36 -0.36 -0.36
Total Stockholders' Equity 8.96 25.65 -22.53 -8.30
Total Liabilities and Stockholders' Equity 173.82 184.19 127.70 141.43

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities -29.16 -18.19 -25.96 -20.35
Net Cash Provided by Investing Activities -0.76 -0.42 0.00 -0.01
Net Cash Provided by Financing Activities 3.38 68.23 5.06 0.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20120.00-22.72-0.36
12/20137.00-46.73-0.58
12/201410.82-111.52-1.23
12/201513.68-123.14-1.19
12/201631.98-161.10-1.52
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1713978,97966.25




Report Date : 12/4/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.